Similar Articles
901 Effects of an oral iron chelator, deferasirox, on advanced hepatocellular carcinoma
902 Insights for hepatitis C virus related hepatocellular carcinoma genetic biomarkers: Early diagnosis and therapeutic intervention
903 Cyclooxygenase-2 expression is associated with initiation of hepatocellular carcinoma, while prostaglandin receptor-1 expression predicts survival
904 Lycopene modulates cellular proliferation, glycolysis and hepatic ultrastructure during hepatocellular carcinoma
905 Polymorphisms of folate metabolism genes in patients with cirrhosis and hepatocellular carcinoma
906 Racial/ethnic disparities in hepatocellular carcinoma treatment and survival in California, 1988-2012
907 Granulocyte colony-stimulating factor-producing hepatocellular carcinoma with abrupt changes
908 Circulating predictive and diagnostic biomarkers for hepatitis B virus-associated hepatocellular carcinoma
909 Hepatocellular carcinoma in patients with non-alcoholic fatty liver disease
910 Prediction models of hepatocellular carcinoma development in chronic hepatitis B patients
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA